Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism

Abstract

The present invention provides for metal chelating compositions which are soluble in aqueous media. The present invention also provides chelating compositions that possess acceptable iron sequestering strengths and are able to present a physical form that potentially inhibits (e.g. does not permit easy) access of iron sequestered by the compositions to the cells being targeted. Compositions comprising chelating aspects affixed to or incorporated into suitable carrier materials such that the resulting metal chelating composition is soluble in aqueous media are also provided. Disclosed herein are chelating compositions, for chelating one or more essential metals. The chelating compositions being soluble in an aqueous medium and comprising one or more metal binding chemical groups affixed to or incorporated into the structure of a carrier material, such that the resulting chelating composition is able to bind one or more metals, and remains substantially soluble in the aqueous medium with its bound metal or metals.

1 - 169 . (canceled) 
     
     
         170 . A chelating composition soluble in an aqueous medium for chelating an essential transition series metal, said chelating composition comprising:
 a carrier material; and   one or more suitable metal binding chemical groups affixed to or incorporated into the structure of the carrier material;   wherein the one or more suitable metal binding chemical groups is one or more of carboxyl, hydroxyl, phenolate, catecholate, hydroxamate or hydroxypyridinone types;   wherein the carrier material comprises vinylpyrrolidone, dextran, starch, styrene or acrylamide;   wherein the chelating composition has a minimum molecular weight sufficiently large so as not to be normally taken up into the intra-cellular aspects internal to a cell membrane of a living cell and is able to bind an essential transition series metal; and   wherein the chelating composition remains substantially soluble in the aqueous medium with its bound essential transition series metal in the external cellular environment of the living cell thereby preventing uptake of the bound essential transition series metal into the intra-cellular aspects internal to the cell membrane of the living cell.   
     
     
         171 . The chelating composition of  claim 170 , wherein the living cell is affected in its growth or activities by having insufficient amounts of the essential transition series metal available for its use. 
     
     
         172 . The chelating composition of  claim 170 , wherein the chelating composition comprises metal binding chemical groups of 3-hydroxy-pyridin-4-one incorporated into the carrier material comprised of vinylpyrrolidone, dextran, starch, or acrylamide. 
     
     
         173 . The chelating composition of  claim 170 , wherein said chelating composition has a molecular weight range defined by a lower molecular weight limit, as measured prior to the binding of a metal or metals, of about 1500 Daltons so as not to be normally taken up into the intra-cellular aspects internal to a cell membrane of a living cell, and a higher molecular weight limit sufficiently low so as to allow the composition to remain soluble in an aqueous medium. 
     
     
         174 . The chelating composition of  claim 170 , wherein the chelating composition is an iodine-containing chelating composition wherein the carrier material is comprised of vinylpyrrolidone or starch bound with iodine, and wherein the iodine-containing chelating composition has anti-microbial properties contributed by the iodine in addition to the metal chelating aspect of the metal chelating composition. 
     
     
         175 . The chelating composition of  claim 170 , wherein the metal chelating composition is for use in treating a disease in an animal, including a fish or a human, that has a disease attributable to a cell or cells, or the activity of a cell or cells, wherein the cell or cells causing the disease are one or more of a microbial cell(s), a cancer cell(s), or a uni-cellular or multi-cellular parasitic organism(s). 
     
     
         176 . The chelating composition of  claim 170 , wherein the metal chelating composition is for administration alone or in conjunction with another anti-cellular agent comprising one or more of an antimicrobial agent, an anti-metabolite agent, an anti-viral agent, an anti-parasitic agent or an anti-cancer agent for use in treating a disease in an animal, including a fish or a human, that has a disease attributable to a cell or cells, or the activity of a cell or cells, wherein the cell or cells causing the disease are one or more of a microbial cell(s), a cancer cell(s), or a uni-cellular or multi-cellular parasitic organism(s). 
     
     
         177 . The chelating composition of  claim 175 , wherein said cell or cells causing the disease are those of the animal itself. 
     
     
         178 . The chelating composition of  claim 170 , wherein the metal chelating composition is for use for affecting the cell or cell activities of one or more spoilage microorganisms in an aqueous based health care or consumer product wherein the metal chelating composition is used to treat the product alone or in conjunction with a chemical preservative agent such that the treatment reduces the extent of microbial growth and/or spoilage in the aqueous based product. 
     
     
         179 . The chelating composition of  claim 171 , wherein the cell or its activity affected by the cell having insufficient uptake of the essential transition series metal is a cell resistant to the activity of another anti-cellular agent, or an activity which is the ability to grow as a biofilm on inanimate or living tissue surfaces. 
     
     
         180 . A pharmaceutical composition comprising the chelating composition of  claim 170 , and a pharmaceutically acceptable carrier, excipient or diluent. 
     
     
         181 . The chelating composition of  claim 171 , for use as an excipient in a pharmaceutical composition with an anti-cellular agent comprising one or more of an antimicrobial agent, an anti-metabolite agent, an anti-viral agent, an anti-parasitic agent or an anti-cancer agent. 
     
     
         182 . The chelating composition of  claim 170 , wherein the metal chelating composition is for administration alone or in conjunction with another anti-cellular agent comprising one or more of an antimicrobial agent, an anti-metabolite agent, an anti-viral agent, an anti-parasitic agent or an anti-cancer agent for use in treating a disease in an animal, including a fish or a human, that has a disease attributable to a cell or cells, or the activity of a cell or cells, wherein the cell or cells causing the disease are one or more of a microbial cell(s), a cancer cell(s), or a uni-cellular or multi-cellular parasitic organism(s). 
     
     
         183 . The chelating composition of  claim 170 , for use as an excipient in a pharmaceutical composition with an anti-cellular agent comprising one or more of an antimicrobial agent, an anti-metabolite agent, an anti-viral agent, an anti-parasitic agent or an anti-cancer agent. 
     
     
         184 . The chelating composition of  claim 171 , wherein the metal chelating composition is for use for affecting the cell or cell activities of one or more spoilage microorganisms in an aqueous based health care or consumer product wherein the metal chelating composition is used to treat the product alone or in conjunction with a chemical preservative agent such that the treatment reduces the extent of microbial growth and/or spoilage in the aqueous based product. 
     
     
         185 . A pharmaceutical composition comprising (a) one or more of an antimicrobial agent, an anti-metabolite agent, an anti-viral agent, an anti-parasitic agent or an anti-cancer agent, and (b) the chelating composition of  claim 170 . 
     
     
         186 . The chelating composition of  claim 170 , wherein the carrier material comprises dextran or starch. 
     
     
         187 . The chelating composition of  claim 170 , wherein the one or more suitable metal binding chemical groups are affixed to the carrier material. 
     
     
         188 . The chelating composition of  claim 186 , wherein the one or more suitable metal binding chemical groups are affixed to the carrier material.